» Articles » PMID: 17644623

Exercise Capacity and Cardiovascular/metabolic Characteristics of Overweight and Obese Individuals with Type 2 Diabetes: the Look AHEAD Clinical Trial

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Jul 24
PMID 17644623
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined associations of cardiovascular, metabolic, and body composition measures with exercise capacity using baseline data from 5,145 overweight and/or obese (BMI > or = 25.0 kg/m2) men and women with type 2 diabetes who were randomized participants for the Look AHEAD (Action for Health in Diabetes) clinical trial.

Research Design And Methods: Peak exercise capacity expressed as METs and estimated from treadmill speed and grade was measured during a graded exercise test designed to elicit a maximal effort. Other measures included waist circumference, BMI, type 2 diabetes duration, types of medication used, A1C, history of cardiovascular disease, metabolic syndrome, beta-blocker use, and race/ethnicity.

Results: Peak exercise capacity was higher for men (8.0 +/- 2.1 METs) than for women (6.7 +/- 1.7 METs) (P < 0.001). Exercise capacity also decreased across each decade of age (P < 0.001) and with increasing BMI and waist circumference levels in both sexes. Older age, increased waist circumference and BMI, a longer duration of diabetes, increased A1C, a history of cardiovascular disease, having metabolic syndrome, beta-blocker use, and being African American compared with being Caucasian were associated with a lower peak exercise capacity for both sexes. Hypertension and use of diabetes medications were associated with lower peak exercise capacity in women.

Conclusions: Individuals with diabetes who are overweight or obese have impaired exercise capacity, which is primarily related to age, female sex, and race, as well as poor metabolic control, BMI, and central obesity.

Citing Articles

Long-term impact of Diabetes Prevention Program interventions on walking endurance.

Munshi M, Venditti E, Tjaden A, Knowler W, Boyko E, Middelbeek R Front Public Health. 2025; 12():1470035.

PMID: 39744353 PMC: 11688401. DOI: 10.3389/fpubh.2024.1470035.


Development of soft tissue asymmetry indicators to characterize aging and functional mobility.

Ricciardi C, Ponsiglione A, Recenti M, Amato F, Gislason M, Chang M Front Bioeng Biotechnol. 2023; 11:1282024.

PMID: 38149173 PMC: 10749973. DOI: 10.3389/fbioe.2023.1282024.


Muscle oxygen utilization and ventilatory parameters during exercise in people with cystic fibrosis: Role of HbA.

Quertermous B, Seigler N, Looney J, Crandall R, Simon A, Blackburn M Chron Respir Dis. 2023; 20:14799731231174542.

PMID: 37166356 PMC: 10184196. DOI: 10.1177/14799731231174542.


Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective observational study.

Frundi D, Kettig E, Popp L, Hoffman M, Dumartin M, Hughes M Front Cardiovasc Med. 2022; 9:907385.

PMID: 35935634 PMC: 9354468. DOI: 10.3389/fcvm.2022.907385.


Factors Associated with Age-Related Declines in Cardiorespiratory Fitness from Early Adulthood Through Midlife: CARDIA.

Pettee Gabriel K, Jaeger B, Sternfeld B, Dooley E, Carnethon M, Jacobs Jr D Med Sci Sports Exerc. 2022; 54(7):1147-1154.

PMID: 35704440 PMC: 9201221. DOI: 10.1249/MSS.0000000000002893.